Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres

NCT06455462 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06455462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06455462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 22, 2024
Completion date
November 25, 2025
Enrollment
352 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma